157 related articles for article (PubMed ID: 25388227)
21. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients.
Berkhout RJ; Bouwes Bavinck JN; ter Schegget J
J Clin Microbiol; 2000 Jun; 38(6):2087-96. PubMed ID: 10834958
[TBL] [Abstract][Full Text] [Related]
22. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion.
Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
Br J Cancer; 1994 Feb; 69(2):222-9. PubMed ID: 8297718
[TBL] [Abstract][Full Text] [Related]
24. Importance of human papillomaviruses for the development of skin cancer.
Meyer T; Arndt R; Christophers E; Nindl I; Stockfleth E
Cancer Detect Prev; 2001; 25(6):533-47. PubMed ID: 12132874
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers.
Weissenborn SJ; Nindl I; Purdie K; Harwood C; Proby C; Breuer J; Majewski S; Pfister H; Wieland U
J Invest Dermatol; 2005 Jul; 125(1):93-7. PubMed ID: 15982308
[TBL] [Abstract][Full Text] [Related]
26. Detection of HPV DNA in trichilemmomas by polymerase chain reaction.
Rohwedder A; Keminer O; Hendricks C; Schaller J
J Med Virol; 1997 Feb; 51(2):119-25. PubMed ID: 9021542
[TBL] [Abstract][Full Text] [Related]
27. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses.
McGregor JM; Farthing A; Crook T; Yu CC; Dublin EA; Levison DA; MacDonald DM
J Am Acad Dermatol; 1994 May; 30(5 Pt 1):701-6. PubMed ID: 8176007
[TBL] [Abstract][Full Text] [Related]
28. Improved detection of cutaneous human papillomavirus DNA by single tube nested 'hanging droplet' PCR.
Forslund O; Ly H; Higgins G
J Virol Methods; 2003 Jun; 110(2):129-36. PubMed ID: 12798239
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma.
Paolini F; Carbone A; Benevolo M; Silipo V; Rollo F; Covello R; Piemonte P; Frascione P; Capizzi R; Catricalà C; Venuti A
J Exp Clin Cancer Res; 2011 Nov; 30(1):108. PubMed ID: 22082146
[TBL] [Abstract][Full Text] [Related]
30. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients.
Shamanin V; Glover M; Rausch C; Proby C; Leigh IM; zur Hausen H; de Villiers EM
Cancer Res; 1994 Sep; 54(17):4610-3. PubMed ID: 8062252
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous human papillomavirus 88: remarkable differences in viral load.
Kullander J; Handisurya A; Forslund O; Geusau A; Kirnbauer R; Dillner J
Int J Cancer; 2008 Jan; 122(2):477-80. PubMed ID: 17935140
[TBL] [Abstract][Full Text] [Related]
32. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
33. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent hosts.
Dokianakis DN; Koumantaki E; Billiri K; Spandidos DA
Int J Mol Med; 2000 Apr; 5(4):405-9. PubMed ID: 10719058
[TBL] [Abstract][Full Text] [Related]
34. Known HPV types have no association with keratoacanthomas.
Lu S; Syrjänen SL; Havu VK; Syrjänen S
Arch Dermatol Res; 1996 Mar; 288(3):129-32. PubMed ID: 8967780
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus status in extragenital nonmelanoma skin cancers.
Drvar DL; Lipozenčić J; Sabol I; Mokos ZB; Ilic I; Grce M
Clin Dermatol; 2014; 32(2):248-52. PubMed ID: 24559560
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?
Klussmann JP; Weissenborn SJ; Wieland U; Dries V; Eckel HE; Pfister HJ; Fuchs PG
Med Microbiol Immunol; 2003 Aug; 192(3):129-32. PubMed ID: 12920586
[TBL] [Abstract][Full Text] [Related]
38. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses.
Kawashima M; Favre M; Obalek S; Jablonska S; Orth G
J Invest Dermatol; 1990 Nov; 95(5):537-42. PubMed ID: 2172390
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors.
Forslund O; Lindelöf B; Hradil E; Nordin P; Stenquist B; Kirnbauer R; Slupetzky K; Dillner J
J Invest Dermatol; 2004 Aug; 123(2):388-94. PubMed ID: 15245440
[TBL] [Abstract][Full Text] [Related]
40. Identification of human papillomavirus in keratoacanthomas.
Forslund O; DeAngelis PM; Beigi M; Schjølberg AR; Clausen OP
J Cutan Pathol; 2003 Aug; 30(7):423-9. PubMed ID: 12859739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
